GeneKor MSA
General information
GeneKor MSA
Spaton 52, Ave., Gerakas
Athens
Attiki
Greece - 15344
http://www.genekor.com/
Organization ID: 505504
Spaton 52, Ave., Gerakas
Athens
Attiki
Greece - 15344
http://www.genekor.com/
Organization ID: 505504
Personnel
- George Nasioulas, Lab Director
Phone: +30 210 6032138
Email: gnasioulas@genekor.com - George Tsaousis, Informatics staff
Phone: +30 210 6032138
Email: gtsaousis@genekor.com
Assertion criteria
Level: Assertion criteria provided
Summary of submissions to ClinVar
Total submissions: 778
Gene
Gene | Submissions | Last Updated |
---|---|---|
ABRAXAS1 | 4 | Mar 6, 2020 |
APC | 27 | Mar 6, 2020 |
ATM | 69 | Mar 6, 2020 |
BARD1 | 15 | Mar 6, 2020 |
BLM | 18 | Mar 6, 2020 |
BMPR1A | 4 | Aug 8, 2018 |
BRCA1 | 143 | Sep 29, 2021 |
BRCA2 | 146 | Sep 29, 2021 |
BRIP1 | 20 | Mar 6, 2020 |
C11orf65 | 25 | Mar 6, 2020 |
CDH1 | 13 | Aug 8, 2018 |
CDK4 | 4 | Aug 8, 2018 |
CDKN2A | 2 | Aug 8, 2018 |
CHEK1 | 1 | Aug 8, 2018 |
CHEK2 | 33 | Sep 29, 2021 |
EPCAM | 5 | Mar 6, 2020 |
LOC106721785 | 2 | Nov 21, 2017 |
LOC106736614 | 1 | Aug 8, 2018 |
LOC107303340 | 2 | Aug 8, 2018 |
LOC111589215 | 1 | Nov 21, 2017 |
LOC126862571 | 17 | Sep 29, 2021 |
LOC129390903 | 2 | Aug 8, 2018 |
MEN1 | 8 | Aug 8, 2018 |
MLH1 | 14 | Mar 6, 2020 |
MRE11 | 13 | Aug 8, 2018 |
MSH2 | 22 | Sep 20, 2022 |
MSH6 | 23 | Sep 29, 2021 |
MUTYH | 15 | Sep 29, 2021 |
NBN | 11 | Sep 29, 2021 |
NF1 | 14 | Mar 6, 2020 |
PALB2 | 31 | Sep 29, 2021 |
PMS2 | 27 | Mar 6, 2020 |
PTEN | 3 | Mar 6, 2020 |
RAD50 | 28 | Sep 29, 2021 |
RAD51B | 9 | Mar 6, 2020 |
RAD51C | 8 | Sep 29, 2021 |
RAD51D | 13 | Aug 8, 2018 |
RAD51L3-RFFL | 13 | Aug 8, 2018 |
RET | 15 | Mar 6, 2020 |
SMAD4 | 1 | Aug 8, 2018 |
STK11 | 4 | Mar 6, 2020 |
TH2-LCR | 1 | Aug 8, 2018 |
TH2LCRR | 4 | Mar 6, 2020 |
TP53 | 10 | Mar 6, 2020 |
TSPAN31 | 3 | Aug 8, 2018 |
VHL | 4 | Mar 6, 2020 |
XRCC2 | 3 | Mar 6, 2020 |
Condition
Name | Submissions | Last Updated |
---|---|---|
Breast-ovarian cancer, familial, susceptibility to, 1 | 5 | Mar 6, 2020 |
Familial cancer of breast | 61 | Sep 29, 2021 |
Hereditary breast ovarian cancer syndrome | 24 | Sep 29, 2021 |
Hereditary cancer-predisposing syndrome | 513 | Sep 29, 2021 |
Hereditary nonpolyposis colon cancer | 1 | Sep 20, 2022 |
Ovarian cancer | 4 | Jan 7, 2020 |
not provided | 103 | Sep 29, 2021 |
not specified | 67 | Nov 21, 2017 |
Testing in GTR
Disease name | Number of tests |
---|---|
Acute lymphoid leukemia | 1 test |
Acute myeloid leukemia | 1 test |
Anaplastic large cell lymphoma | 1 test |
Attenuated familial adenomatous polyposis | 2 tests |
Breast adenocarcinoma | 1 test |
Breast lobular carcinoma | 1 test |
Breast neoplasm | 2 tests |
Breast-ovarian cancer, familial, susceptibility to, 1 | 1 test |
Breast-ovarian cancer, familial, susceptibility to, 2 | 1 test |
Carcinoma of colon | 2 tests |
Carcinoma of pancreas | 2 tests |
Chronic myelogenous leukemia, BCR-ABL1 positive | 1 test |
Endometrial carcinoma | 2 tests |
Familial adenomatous polyposis 1 | 2 tests |
Familial cancer of breast | 3 tests |
Familial colorectal cancer | 4 tests |
Familial medullary thyroid carcinoma | 1 test |
Familial pancreatic carcinoma | 2 tests |
Gardner syndrome | 2 tests |
Gastrointestinal stromal tumor | 1 test |
Glioma | 1 test |
Hereditary breast ovarian cancer syndrome | 1 test |
Hereditary diffuse gastric adenocarcinoma | 1 test |
Lung carcinoma | 1 test |
Lynch syndrome | 3 tests |
Melanoma | 2 tests |
Mismatch repair cancer syndrome 1 | 3 tests |
Muir-Torré syndrome | 2 tests |
Multiple endocrine neoplasia type 2A | 1 test |
Multiple endocrine neoplasia type 2B | 1 test |
Multiple endocrine neoplasia, type 1 | 1 test |
Multiple endocrine neoplasia, type 2 | 1 test |
Myelodysplastic syndrome | 1 test |
Non-small cell lung carcinoma | 1 test |
Ovarian cancer | 1 test |
Ovarian neoplasm | 3 tests |
Solid tumor | 1 test |
Thyroid gland carcinoma | 1 test |
Von Hippel-Lindau syndrome | 1 test |